We are live on ! Find out more
ICP

Interchange Capital Partners Portfolio holdings

AUM $532M
1-Year Est. Return 26.57%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+26.57%
3 Year Est. Return
+79.59%
5 Year Est. Return
+78.72%
10 Year Est. Return
AUM
$184M
AUM Growth
+$50K
Cap. Flow
-$35.5M
Cap. Flow %
-19.26%
Top 10 Hldgs %
22.99%
Holding
1,250
New
7
Increased
100
Reduced
116
Closed
1,019

Top Sells

Rank Stock Value
1
TLRY icon
Tilray
TLRY
+$1.21M
2
QUAL icon
iShares MSCI USA Quality Factor ETF
QUAL
+$853K
3
TSLA icon
Tesla
TSLA
+$693K
4
PINS icon
Pinterest
PINS
+$688K
5
AAPL icon
Apple
AAPL
+$572K

Sector Composition

Rank Sector Weight
1 Technology 13.53%
2 Healthcare 12.09%
3 Financials 9.23%
4 Consumer Discretionary 7.37%
5 Communication Services 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPTX
1201
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
-32
Closed -$3K
ACC
1202
DELISTED
American Campus Communities, Inc.
ACC
-89
Closed -$3K
PSTH.WS
1203
DELISTED
Pershing Square Tontine Holdings, Ltd. Warrants, exercisable for one share of Class A Common Stock f
PSTH.WS
-1,333
Closed -$12K
CDK
1204
DELISTED
CDK Global, Inc.
CDK
-128
Closed -$6K
COHR
1205
DELISTED
Coherent Inc
COHR
-23
Closed -$3K
CERN
1206
DELISTED
Cerner Corp
CERN
-100
Closed -$7K
ZNGA
1207
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
-4,860
Closed -$47K
FOE
1208
DELISTED
Ferro Corporation
FOE
-500
Closed -$7K
CONE
1209
DELISTED
CyrusOne Inc Common Stock
CONE
-542
Closed -$39K
ARNA
1210
DELISTED
Arena Pharmaceuticals Inc
ARNA
-31
Closed -$2K
XLNX
1211
DELISTED
Xilinx Inc
XLNX
-180
Closed -$25K
RDS.A
1212
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
-503
Closed -$17K
RDS.B
1213
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
-183
Closed -$6K
ODT
1214
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
-18
Closed
DRNA
1215
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-69
Closed -$1K
COR
1216
DELISTED
Coresite Realty Corporation
COR
-31
Closed -$3K
HRC
1217
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
-125
Closed -$12K
XLRN
1218
DELISTED
Acceleron Pharma
XLRN
-201
Closed -$25K
XEC
1219
DELISTED
CIMAREX ENERGY CO
XEC
-361
Closed -$13K
PFPT
1220
DELISTED
Proofpoint, Inc.
PFPT
-62
Closed -$8K
MXIM
1221
DELISTED
Maxim Integrated Products
MXIM
-56
Closed -$4K
ALXN
1222
DELISTED
Alexion Pharmaceuticals
ALXN
-323
Closed -$50K
WORK
1223
DELISTED
Slack Technologies, Inc.
WORK
-2,384
Closed -$100K
MSGN
1224
DELISTED
MSG Networks Inc.
MSGN
-209
Closed -$3K
PRAH
1225
DELISTED
PRA Health Sciences, Inc.
PRAH
-29
Closed -$3K

Similar funds

Interchange Capital Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Interchange Capital Partners held 1,250 positions worth $184M, up 0.03% from $184M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Interchange Capital Partners withdrew a net $35.5M in Q1 2021, closing 1,019 positions and reducing 116 holdings. Its most notable exit was Tilray, an estimated $1.21M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Interchange Capital Partners opened a new position in iShares Latin America 40 ETF worth $767K.

  • Interchange Capital Partners's largest Q1 2021 buy was iShares Latin America 40 ETF: 27,803 shares worth $767K.
  • Interchange Capital Partners added most to iShares Russell 2000 Value ETF in Q1 2021, an estimated $1.25M increase.
  • Interchange Capital Partners's biggest Q1 2021 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $853K.
  • Interchange Capital Partners fully exited Tilray in Q1 2021, selling an estimated $1.21M.
  • Interchange Capital Partners's ten largest holdings make up 23% of its $184M portfolio in Q1 2021.
  • Interchange Capital Partners opened 7 new positions and closed 1,019 in Q1 2021.
  • Interchange Capital Partners's portfolio value rose 0.03% quarter-over-quarter to $184M.

Based on Interchange Capital Partners's 13F filing for Q1 2021, filed 5 May 2021.